These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37453562)

  • 1. Purinergic receptors in cognitive disturbances.
    Illes P; Ulrich H; Chen JF; Tang Y
    Neurobiol Dis; 2023 Sep; 185():106229. PubMed ID: 37453562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic receptors in psychiatric disorders.
    Krügel U
    Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of purinergic signaling in depressive disorders.
    Sperlagh B; Csolle C; Ando RD; Goloncser F; Kittel A; Baranyi M
    Neuropsychopharmacol Hung; 2012 Dec; 14(4):231-8. PubMed ID: 23269209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic Signalling and Neurological Diseases: An Update.
    Burnstock G
    CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic transmission in blood vessels.
    Ralevic V; Dunn WR
    Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes and major depression: The purinergic avenue.
    Zhao YF; Verkhratsky A; Tang Y; Illes P
    Neuropharmacology; 2022 Dec; 220():109252. PubMed ID: 36122663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
    Merighi S; Poloni TE; Terrazzan A; Moretti E; Gessi S; Ferrari D
    Cells; 2021 May; 10(5):. PubMed ID: 34065393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington's and Parkinson's Disease.
    Glaser T; Andrejew R; Oliveira-Giacomelli Á; Ribeiro DE; Bonfim Marques L; Ye Q; Ren WJ; Semyanov A; Illes P; Tang Y; Ulrich H
    Neurosci Bull; 2020 Nov; 36(11):1299-1314. PubMed ID: 33026587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic signaling in Alzheimer's disease.
    Erb L; Woods LT; Khalafalla MG; Weisman GA
    Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of purinergic receptors in the Alzheimer's disease.
    Cieślak M; Wojtczak A
    Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
    Resende RR; Britto LR; Ulrich H
    Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression.
    Sikka P; Behl T; Chandel P; Sehgal A; Singh S; Makeen HA; Albratty M; Alhazmi HA; Meraya AM
    Neurotox Res; 2022 Oct; 40(5):1570-1585. PubMed ID: 35930172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signaling in diabetes and metabolism.
    Jain S; Jacobson KA
    Biochem Pharmacol; 2021 May; 187():114393. PubMed ID: 33359363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to Purinergic Signaling.
    Burnstock G
    Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS.
    Illes P; Rubini P; Ulrich H; Zhao Y; Tang Y
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
    Pan L; Ma Y; Li Y; Wu H; Huang R; Cai Z; Wu X
    Mini Rev Med Chem; 2021; 21(11):1288-1302. PubMed ID: 33302833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
    Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
    Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.